Individual visual simulation: from target to preclinical shortlist
Biomedical AI
Drug discovery from AI
The simulation models the pipeline: target profiling, molecule generation, docking, ADMET filtering, and preclinical shortlist. Changing model parameters immediately affects stage passability and expected program efficacy.
42k/day
Screening speed
63%
Success probability
28%
Toxicity risk
14.6 months
Time to lead
Dataset quality
Model depth
Compute budget
Novelty bias
Safety threshold
System stable: prioritize docking optimization and toxicity control.